Perioperative administration of recombinant activated factor VII in a Glanzmannʼs thrombasthenia patient with platelet refractoriness: case report

Abstract Glanzmannʼs Trombasthenia (GT) is a genetic disorder, that develops with a tendency toward bleeding and is characterized by the absence or decrease in platelet aggregation. Surgical bleeding may be difficult to control. Platelet transfusion is the main treatment, albeit refractoriness can occur. We describe the case of a patient with GT and platelet refractoriness, who was submitted to radical prostatectomy and dental extraction. The perioperative treatment with apheresis platelet concentrate and activated recombinant factor seven allowed the procedures to be performed uneventfully. We discuss the complexity of the case and the treatment option.

Saved in:
Bibliographic Details
Main Authors: Bisinotto,Flora Margarida Barra, Martins,Laura Bisinotto, Camargos,Giovanini Pires de, Bianco,Marcelo de Paula
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Anestesiologia (SBA) 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2352-22912022000600823
Tags: Add Tag
No Tags, Be the first to tag this record!